HUP0401912A3 - Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them - Google Patents
Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0401912A3 HUP0401912A3 HU0401912A HUP0401912A HUP0401912A3 HU P0401912 A3 HUP0401912 A3 HU P0401912A3 HU 0401912 A HU0401912 A HU 0401912A HU P0401912 A HUP0401912 A HU P0401912A HU P0401912 A3 HUP0401912 A3 HU P0401912A3
- Authority
- HU
- Hungary
- Prior art keywords
- camptothecins
- preparation
- pharmaceutically acceptable
- pharmaceutical compositions
- acceptable salts
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN798MA2001 | 2001-09-25 | ||
| PCT/IB2002/003950 WO2003027118A1 (en) | 2001-09-25 | 2002-09-25 | Pharmaceutically acceptable salts of 20(s)-camptothecins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0401912A2 HUP0401912A2 (hu) | 2005-01-28 |
| HUP0401912A3 true HUP0401912A3 (en) | 2007-02-28 |
Family
ID=33042623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401912A HUP0401912A3 (en) | 2001-09-25 | 2002-09-25 | Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7071203B2 (hu) |
| EP (1) | EP1430059B1 (hu) |
| JP (1) | JP2005507893A (hu) |
| KR (1) | KR20040039404A (hu) |
| CN (1) | CN1575292A (hu) |
| AT (1) | ATE318823T1 (hu) |
| BR (1) | BR0212990A (hu) |
| CA (1) | CA2461089A1 (hu) |
| DE (1) | DE60209517D1 (hu) |
| HU (1) | HUP0401912A3 (hu) |
| IL (1) | IL160982A0 (hu) |
| MX (1) | MXPA04002784A (hu) |
| NO (1) | NO20041643L (hu) |
| NZ (1) | NZ531878A (hu) |
| PL (1) | PL368229A1 (hu) |
| RU (1) | RU2004109163A (hu) |
| WO (1) | WO2003027118A1 (hu) |
| ZA (1) | ZA200402321B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003068778A1 (en) * | 2002-02-18 | 2003-08-21 | Dr. Reddy's Laboratories Limited | A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride |
| TWI333492B (en) * | 2003-11-12 | 2010-11-21 | Smithkline Beecham Cork Ltd | Crystalline topotecan hydrochloride product and preparation thereof |
| WO2006038526A1 (ja) * | 2004-10-01 | 2006-04-13 | Kabushiki Kaisha Yakult Honsha | イリノテカン酸付加塩 |
| ITMI20061473A1 (it) * | 2006-07-26 | 2008-01-27 | Indena Spa | Derivati della camptotecina ad attivita antitumorale |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1025029C (zh) * | 1988-10-22 | 1994-06-15 | 沈阳药学院 | 喜树硷精氨酸盐制剂的制备方法 |
| US6177439B1 (en) * | 1995-06-06 | 2001-01-23 | Reddy's Research Foundation | Water soluble analogues of 20(S)-camptothecin |
| JP4094710B2 (ja) * | 1997-11-06 | 2008-06-04 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
-
2002
- 2002-09-25 HU HU0401912A patent/HUP0401912A3/hu unknown
- 2002-09-25 AT AT02772643T patent/ATE318823T1/de not_active IP Right Cessation
- 2002-09-25 CN CNA028210840A patent/CN1575292A/zh active Pending
- 2002-09-25 DE DE60209517T patent/DE60209517D1/de not_active Expired - Lifetime
- 2002-09-25 WO PCT/IB2002/003950 patent/WO2003027118A1/en active IP Right Grant
- 2002-09-25 PL PL02368229A patent/PL368229A1/xx not_active Application Discontinuation
- 2002-09-25 MX MXPA04002784A patent/MXPA04002784A/es unknown
- 2002-09-25 KR KR10-2004-7004255A patent/KR20040039404A/ko not_active Application Discontinuation
- 2002-09-25 RU RU2004109163/04A patent/RU2004109163A/ru not_active Application Discontinuation
- 2002-09-25 JP JP2003530706A patent/JP2005507893A/ja not_active Withdrawn
- 2002-09-25 NZ NZ531878A patent/NZ531878A/en unknown
- 2002-09-25 EP EP02772643A patent/EP1430059B1/en not_active Expired - Lifetime
- 2002-09-25 US US10/490,552 patent/US7071203B2/en not_active Expired - Fee Related
- 2002-09-25 BR BR0212990-6A patent/BR0212990A/pt not_active IP Right Cessation
- 2002-09-25 CA CA002461089A patent/CA2461089A1/en not_active Abandoned
- 2002-09-25 IL IL16098202A patent/IL160982A0/xx unknown
-
2004
- 2004-03-24 ZA ZA200402321A patent/ZA200402321B/xx unknown
- 2004-04-22 NO NO20041643A patent/NO20041643L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0212990A (pt) | 2004-09-21 |
| CN1575292A (zh) | 2005-02-02 |
| NZ531878A (en) | 2006-04-28 |
| KR20040039404A (ko) | 2004-05-10 |
| NO20041643L (no) | 2004-04-22 |
| ZA200402321B (en) | 2005-01-13 |
| HUP0401912A2 (hu) | 2005-01-28 |
| RU2004109163A (ru) | 2005-10-10 |
| US7071203B2 (en) | 2006-07-04 |
| ATE318823T1 (de) | 2006-03-15 |
| PL368229A1 (en) | 2005-03-21 |
| WO2003027118A1 (en) | 2003-04-03 |
| DE60209517D1 (de) | 2006-04-27 |
| MXPA04002784A (es) | 2004-07-29 |
| EP1430059B1 (en) | 2006-03-01 |
| IL160982A0 (en) | 2004-08-31 |
| EP1430059A1 (en) | 2004-06-23 |
| CA2461089A1 (en) | 2003-04-03 |
| JP2005507893A (ja) | 2005-03-24 |
| US20040198760A1 (en) | 2004-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0303891A3 (en) | Pharmaceutically active piridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PL396568A1 (pl) | Krystaliczny bursztynian O-demetylo-wenlafaksyny, kompozycja farmaceutyczna, farmaceutyczna postać dawkowania, doustna postać dawkowania, zastosowanie oraz sposób wytwarzania krystalicznego bursztynianu O-demetylo-wenlafaksyny | |
| PL355844A1 (en) | Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation | |
| HUP0304082A3 (en) | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
| HUP0400246A3 (en) | 1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use | |
| HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
| HUP0204563A3 (en) | Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions | |
| HUP0202233A3 (en) | Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them | |
| HUP0301080A3 (en) | Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102631A3 (en) | 1,1- and 1,2-disubstituted cyclopropane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102895A3 (en) | Cyclopentanone dihydropyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0302291A3 (en) | Sulfonamide derivatives, process for their preparation and their use for preparation of pharmaceutical compositions | |
| HUP0203859A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| HUP0200343A3 (en) | Phenylalaninol derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| SI1245565T1 (en) | Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0400773A3 (en) | 7-(4-tert-butylyclohexyl)-5-ethyl-3h-imidazo[5,1-f][1,2,4]triazin-4-on derivatives, their use pharmaceutical compositions containing them and process for the preparation of the compounds | |
| HUP0401912A3 (en) | Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them | |
| HUP0200913A3 (en) | Isoindoindololone derivatives process for their preparation and pharmaceutical compositions containing them | |
| HUP0200993A3 (en) | Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them | |
| HUP0303110A3 (en) | 5-amino-1-pentene-3-ol substituted derivatives, process for their preparation and pharmaceutical compositions containing them and their use | |
| HUP0303238A3 (en) | Hiv inhibiting n-aminoimidazole derivatives, their use, process for their preparation and pharmaceutical compositions containing them |